Axis Bank announces financial results for the Quarter and Half -

Axis Bank announces financial results for the Quarter and Half -

Year Ended 30th Sept. 2015 Results at a Glance :- " Net Profit for Q2FY16 and H1FY16 grew 19% YOY to `1,916 crores and `3,894 crores respectively " The Bank's Retail franchise continued to perform well CASA, on a daily average basis for Q2FY16, grew 14% YOY and constitutes 40% of Total Deposits Retail Term Deposits grew 18% YOY and constitutes 64% of Term Deposits, CASA and Retail Term Deposits constitutes 80% of Total Deposits, Retail Advances growth continues to be strong at 27% YOY and accounts for 40% of Net Advances Retail Fee Income in Q2FY16 grew 19% YOY and constitutes 40% of Total Fee Income " Asset Quality is healthy with Net NPAs at 0.48% " The Bank is well capitalised with a healthy Capital Adequacy Ratio (CAR). Under Basel III, Total CAR & Tier I CAR (including the net profit for H1FY16) stood at 15.42% and 12.21% respectively

Comments

Best Buy For Monday Upper Circuit Expected TCI FINANCE

*Intraday & Short Term News For Monday* *Fii And Dii News* *TCI FINANCE LTD (501242 & NSE) (31)* Incorporated in 1973, TCI Finance Ltd (TCIFL) is a Non-Banking Finance Company (NBFC) registered with the RBI and engaged in the business of Inter-Corporate Deposits, investment in equities of bodies corporate etc. The Company was promoted by Mr. Mahendra Agarwal, who is also the Managing Director and CEO of Gati Ltd, a pioneer in express distribution and supply chain and promoted by TCFIL The Rs.2 paid-up share of Gati Ltd currently trades at Rs.113. TCIFL has one subsidiary - ITAG Business Solutions Ltd engaged in the business of Knowledge Process Outsourcing (KPO) in the domain of Intellectual Property Services. *It is co-promoter of GATI LTD. Company is holding 55,12,455 shares (5.09%) stake in GATI LTD. At CMP value of investments is around Rs.62.3crore. Equity is Rs.12.87crore. Thus value of investment works out to Rs.48.4 per share ...

SSPDL LTD Big Play

SSPDL LTD It is a small company having presence in South India. It has presence in Chennai, Hyderabad, Kerala and Bangalore. Only BSE listed company. But Circuit Filter is at 20%. From Annual Report: Company is primarily focusing on the development of land, plotted lands, mid-size houses, etc. and reduce the construction contracts work. In view of the projects of the Company under execution and in pipe line, the management is expecting better prospects in future for the company. During the year under review Company given loan of Rs 2.80 crore bearing 18% interest per annum to M/s. BHEL Employees Model Mutually Aided Co-operative House Building Society Limited for meeting the shortfall of amount in paying stamp duty for registering plots in Society’s Name. Projects completed during the year 2014-15: - (1). Frangipani, Pudupakkam, and (2). Meeting House/Service Centre, Bangalore. Regarding Ongoing Projects: 23 Cr is yet to receive from IT park (Alpha City pro...

Cipla Ltd ( Ready To Fly In Sky No One Catch It)

Cipla Ltd. (BSE Code: 500087) (CMP: Rs.654.95) (FV: Rs.2) (TGT: Rs.1500) Cipla Ltd is a pharmaceutical company with business units focused on Active Pharmaceutical Ingredients (APIs), Respiratory and Cipla Global Access. The Company offers APIs, formulations and veterinary products. As of 31 March 2015, Cipla offered services across five continents and in countries like India, South Africa, Europe and North America, among others. It offers over 1,000 products across 120 countries that treat cardiovascular diseases, children’s health, dermatology and cosmetology, diabetes, Human Immunodeficiency Virus/Acquired Immuno Deficiency syndrome (HIV/AIDS), infectious diseases and critical care, malaria, neurosciences, oncology, ophthalmology, osteoporosis, respiratory, urology and women’s health. It also offers veterinary products in categories such as companion, equine, general care, livestock and poultry. Cipla’s UK arm has entered into an agreement to acquire two US-based companies...

Value Research

Search This Blog